Ke Wang
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH).
Journal: Cancer biology & medicine
Published: May 22, 2026
Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.
Journal: Cancer communications (London, England)
Published: November 29, 2025
Immunotherapy in EGFR-mutant non-small cell lung cancer.
Journal: Clinical and experimental medicine
Published: September 03, 2025
Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited-stage small-cell lung cancer: A retrospective, multi-center, real-world study.
Journal: International journal of cancer
Published: May 20, 2025
Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports.
Journal: Discover oncology
Published: February 17, 2025
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study.
Journal: The Lancet. Respiratory medicine
Published: August 11, 2024
Prevention of Spontaneous Premature Birth With Cervical Pessary: A Single-Center Prospective Cohort Study
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: May 21, 2024
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study.
Journal: The Lancet. Respiratory medicine
Published: February 15, 2024
Maternal infection with hepatitis B virus before pregnancy and risk of congenital malformations in offspring: a record-linkage study of a large national sample from China.
Journal: The Lancet regional health. Western Pacific
Published: December 01, 2023
Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients.
Journal: Cancer medicine
Published: November 27, 2023
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 14, 2023
The maternal drug exposure birth cohort (DEBC) in China.
Journal: Nature communications
Published: March 06, 2023
Last Updated: 09/26/2026